The Nordic AML Group (NAMLG) aim to foster excellence in research and clinical care in acute myeloid leukemia (AML) in the Nordic countries, by forming an active network of clinicians and basic and translational scientists with deep interest and experience in the field.
Photo: NASA
.
We greatly value your feedback to help us improve future meetings whereby all attendees are asked to fill in this evaluation form (2-3 minutes). Your input will guide us as we plan ahead — and we already look forward to welcoming you back to Bergen for the next NAMLG meeting, September 16–18, 2026 with more information here.
[News? Please, let us know via namlgewg@gmail.com.]
Gösta Gahrton and Gunnar Juliusson are the editors of the Swedish-language textbook Blodets sjukdomar, which has just been released in a new, extensively revised and expanded edition. The book reflects the rapid advances in hematology – from molecular diagnostics and clonal hematopoiesis to targeted therapies and cell-based treatments.
All chapters have been thoroughly updated, and several entirely new sections have been added, covering topics such as clonal hematopoiesis, hereditary predisposition, mastocytosis, and advanced cell therapy. The book serves both as a modern introduction for physicians in training and as a practical reference for established specialists wishing to stay current with this fast-moving field.
Now available at studentlitteratur.se.
The European School of Haematology is looking for 2 Young Scientific Reporters, to cover the 7th International Conference on Acute Myeloid Leukemia “Molecular and Translational: Advances in Biology and Treatment”, October 16-18 in Estoril, Portugal.
Find more info and the application form using this link.
Deadline: 2025-09-08.
There was a well-attended NAMLG lunch meetng in Munich 2025-03-17. The meeting started with an update on ongoing NAMLG activities with a focus on the upcoming NAMLG meeting in Bergen.
After remarks from the sponsor, Servier, we had an update on the LD-VenEx study followed by an IIS study proposal.
Results from the Finnish VenEx trial (NCT04267081) have now been published in Blood. You can find the publication by using this link.
[Have an event? Please, let us know via namlgewg@gmail.com.]
Click here to add your own text
